XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $815 | -11.3% | 23,866 | 0.0% | 0.31% | -15.0% |
| Q2 2023 | $919 | -35.8% | 23,866 | -40.3% | 0.37% | -35.0% |
| Q1 2023 | $1,432 | -39.0% | 40,000 | -32.8% | 0.56% | -36.5% |
| Q4 2022 | $2,346 | -99.9% | 59,500 | 0.0% | 0.89% | -2.0% |
| Q3 2022 | $2,148,000 | +18.7% | 59,500 | 0.0% | 0.90% | +18.9% |
| Q2 2022 | $1,810,000 | -11.0% | 59,500 | -10.5% | 0.76% | +17.3% |
| Q1 2022 | $2,033,000 | -24.8% | 66,500 | -23.1% | 0.65% | -29.3% |
| Q4 2021 | $2,702,000 | – | 86,488 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |